US
CA
NZ
UK
AU
IND
Last update at 2025-07-07T20:00:00Z
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Income before tax | 1030.93M | 850.21M | 1604.66M | 1565.20M | 1527.92M |
| Minority interest | - | - | - | - | 0.00000M |
| Net income | 611.78M | 508.48M | 1136.69M | 1005.05M | 843.15M |
| Selling general administrative | 5962.92M | 5667.59M | 5283.09M | 5131.40M | 4306.79M |
| Selling and marketing expenses | - | - | - | - | - |
| Gross profit | 7703.49M | 7247.98M | 7186.99M | 7228.54M | 6739.72M |
| Reconciled depreciation | 311.28M | 305.48M | 284.25M | 256.43M | 175.38M |
| Ebit | 1358.40M | 1325.22M | 1739.54M | 1850.11M | 2214.31M |
| Ebitda | 1872.51M | 1419.43M | 2132.93M | 2186.17M | 2118.70M |
| Depreciation and amortization | - | - | - | - | - |
| Non operating income net other | - | - | - | - | 0.00000M |
| Operating income | 1771.97M | 1615.47M | 1954.98M | 1848.08M | 2227.09M |
| Other operating expenses | 382.17M | 330.72M | 177.12M | 249.07M | 205.84M |
| Interest expense | 530.29M | 263.74M | 244.02M | 364.55M | 415.40M |
| Tax provision | 419.15M | 341.73M | 467.97M | 560.15M | 684.78M |
| Interest income | 20.02M | 11.88M | 18.70M | 20.23M | 24.12M |
| Net interest income | -542.12400M | -251.85700M | -225.32700M | -344.31600M | -425.27500M |
| Extraordinary items | - | - | - | - | 0.00000M |
| Non recurring | - | - | - | - | 0.00000M |
| Other items | - | - | - | - | 0.00000M |
| Income tax expense | 419.15M | 341.73M | 467.97M | 560.15M | 684.78M |
| Total revenue | 12775.91M | 11547.83M | 11194.68M | 10925.22M | 10132.50M |
| Total operating expenses | 11003.94M | 9932.35M | 9239.70M | 9077.14M | 7905.41M |
| Cost of revenue | 5072.43M | 4299.84M | 4007.69M | 3696.68M | 3392.78M |
| Total other income expense net | - | - | - | -282.87600M | -699.16400M |
| Discontinued operations | - | - | - | - | 0.00000M |
| Net income from continuing ops | 611.78M | 508.48M | 1136.69M | 1005.05M | 843.15M |
| Net income applicable to common shares | 611.78M | 508.48M | 1136.69M | 1005.05M | 843.15M |
| Preferred stock and other adjustments | - | - | - | - | 0.00000M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Total assets | 20963.03M | 20281.75M | 17218.42M | 15861.37M | 14854.59M |
| Intangible assets | 5639.31M | 5572.44M | 3579.67M | 3668.42M | 3646.15M |
| Earning assets | - | - | - | - | - |
| Other current assets | 19.70M | 6.74M | 43.46M | 11.30M | 23.77M |
| Total liab | 14821.17M | 14396.56M | 11015.74M | 10267.57M | 10005.04M |
| Total stockholder equity | 6141.85M | 5885.19M | 6202.69M | 5593.81M | 4849.55M |
| Deferred long term liab | - | - | - | - | 0.00000M |
| Other current liab | 2785.30M | 2771.45M | 2576.80M | 2296.34M | 2135.73M |
| Common stock | 5.52M | 5.52M | 5.51M | 5.50M | 5.47M |
| Capital stock | 5.52M | 5.52M | 5.51M | 5.50M | 5.47M |
| Retained earnings | 220.72M | 6673.36M | 6558.00M | 6283.73M | 5524.85M |
| Other liab | 1025.47M | 1060.01M | 1111.23M | 1032.48M | 1072.76M |
| Good will | 7684.09M | 7471.99M | 6648.70M | 5467.49M | 5295.24M |
| Other assets | 827.72M | 658.87M | 744.37M | 503.60M | 651.84M |
| Cash | 2303.66M | 2400.07M | 1830.87M | 2217.34M | 1912.39M |
| Cash and equivalents | - | - | - | - | - |
| Total current liabilities | 5134.88M | 6821.93M | 3277.70M | 3203.05M | 3201.69M |
| Current deferred revenue | - | - | - | - | - |
| Net debt | 7264.63M | 6975.21M | 4193.48M | 3659.01M | 4054.54M |
| Short term debt | - | - | - | 21.53M | 0.00000M |
| Short long term debt | 986.65M | 3145.49M | 20.23M | 21.53M | 236.35M |
| Short long term debt total | - | - | - | - | - |
| Other stockholder equity | 5915.62M | -1509.77200M | -1061.49900M | -1375.55000M | -1297.52100M |
| Property plant equipment | 531.10M | 589.29M | 603.49M | 678.92M | 480.29M |
| Total current assets | 5859.42M | 5513.46M | 4968.55M | 5197.60M | 4532.56M |
| Long term investments | - | - | - | 402.68M | 270.94M |
| Net tangible assets | -7181.54700M | -7159.24400M | -4025.68300M | -3484.77000M | -4034.51800M |
| Short term investments | - | - | - | - | 3.52M |
| Net receivables | 769.05M | 835.19M | 902.77M | 1265.28M | 956.14M |
| Long term debt | 8581.64M | 6229.79M | 6004.12M | 5854.81M | 5730.59M |
| Inventory | 2587.70M | 2087.72M | 1958.06M | 1550.35M | 1565.15M |
| Accounts payable | 1340.97M | 881.46M | 637.82M | 837.75M | 829.61M |
| Total permanent equity | - | - | - | - | 0.00000M |
| Noncontrolling interest in consolidated entity | - | - | - | - | 0.00000M |
| Temporary equity redeemable noncontrolling interests | - | - | - | - | 0.00000M |
| Accumulated other comprehensive income | - | - | - | - | 0.00000M |
| Additional paid in capital | - | - | - | - | 0.00000M |
| Common stock total equity | - | - | - | - | 0.00000M |
| Preferred stock total equity | - | - | - | - | 0.00000M |
| Retained earnings total equity | - | - | - | - | 0.00000M |
| Treasury stock | - | - | - | - | 0.00000M |
| Accumulated amortization | - | - | - | - | 0.00000M |
| Non currrent assets other | - | - | - | - | 0.00000M |
| Deferred long term asset charges | - | - | - | - | 0.00000M |
| Non current assets total | 15103.61M | 14768.28M | 12249.87M | 10663.77M | 10322.02M |
| Capital lease obligations | 101.14M | 102.58M | 149.11M | 162.35M | 0.00000M |
| Long term debt total | - | - | - | - | 0.00000M |
| Breakdown | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 | 2018-12-31 |
| Investments | -29.58100M | 1.72M | -80.17700M | -159.17700M | -0.38500M |
| Change to liabilities | 0.00000M | 333.83M | -197.94500M | 36.51M | 283.63M |
| Total cashflows from investing activities | - | -4010.58600M | -1240.29800M | -277.18700M | -748.59900M |
| Net borrowings | -607.83600M | 3457.38M | 413.52M | -384.30100M | -722.83000M |
| Total cash from financing activities | -1489.80100M | 2768.39M | -687.67600M | -869.12100M | -1118.85900M |
| Change to operating activities | - | 44.80M | 235.14M | 36.54M | 339.97M |
| Net income | 611.78M | 508.48M | 1136.69M | 1005.05M | 843.15M |
| Change in cash | -125.36400M | 569.20M | -386.46200M | 304.94M | -177.88600M |
| Begin period cash flow | 2400.07M | 1830.87M | 2217.34M | 1912.39M | 2090.28M |
| End period cash flow | 2297.66M | 2400.07M | 1830.87M | 2217.34M | 1912.39M |
| Total cash from operating activities | 1469.31M | 1890.08M | 1532.55M | 1439.24M | 1697.21M |
| Issuance of capital stock | -56.90100M | 11.83M | 18.36M | 48.31M | 39.36M |
| Depreciation | 311.28M | 279.07M | 265.15M | 245.79M | 169.39M |
| Other cashflows from investing activities | - | 11.05M | 17.72M | 18.22M | 55.76M |
| Dividends paid | 233.62M | -407.51800M | -862.11000M | -271.51800M | 271.52M |
| Change to inventory | -706.74400M | -164.12500M | -480.30000M | -19.59400M | -640.22600M |
| Change to account receivables | - | 41.74M | 361.19M | -230.23300M | -184.33900M |
| Sale purchase of stock | - | - | - | - | 0.00000M |
| Other cashflows from financing activities | - | -293.30000M | -257.45000M | -261.60800M | -435.38800M |
| Change to netincome | - | 819.87M | 193.52M | 354.55M | 879.65M |
| Capital expenditures | 102.49M | 53.27M | 81.33M | 104.97M | 63.19M |
| Change receivables | - | - | - | - | 0.00000M |
| Cash flows other operating | - | - | - | - | 0.00000M |
| Exchange rate changes | - | - | - | - | 0.00000M |
| Cash and cash equivalents changes | - | - | - | - | 0.00000M |
| Change in working capital | -201.12000M | 256.25M | -81.91200M | -176.78000M | -200.96500M |
| Stock based compensation | -44.54200M | 42.45M | 48.46M | 57.52M | - |
| Other non cash items | 477.26M | 254.66M | 267.86M | 400.53M | 455.26M |
| Free cash flow | 1366.82M | 1783.49M | 1426.06M | 1306.56M | 1434.88M |
Sector: Consumer Defensive Industry: Packaged Foods
| Company | Change (USD) | Price (USD) | Trailing PE (x) | Forward PE (x) | Price Sales TTM (x) | Price to Book Value (x) | Enterprise Value to Revenue (x) | Enterprise Value to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| BTSDF Health and Happiness (H&H) International Holdings Limited |
- -% | 1.26 | 7.28 | - | 0.07 | 0.81 | 0.15 | 0.93 |
| NSRGF Nestle SA |
-0.334 0.34% | 98.25 | 26.86 | 18.76 | 3.13 | 7.10 | 3.81 | 21.70 |
| NSRGY Nestle SA ADR |
-0.22 0.22% | 98.04 | 26.82 | 18.66 | 3.18 | 7.07 | 3.81 | 21.70 |
| KHC Kraft Heinz Co |
0.18 0.71% | 26.27 | 15.59 | 11.79 | 1.64 | 0.88 | 2.34 | 11.32 |
| DANOY Danone PK |
-0.16 1.00% | 15.78 | 28.42 | 16.39 | 1.44 | 2.23 | 1.85 | 12.41 |
Health and Happiness (H&H) International Holdings Limited, an investment holding company, manufactures and sells pediatric nutrition, baby care products, adult nutrition and care products, and pet nutrition and care products worldwide. The company's infant formulas segment produces infant formulas for children under seven years old and milk formulas for expectant and nursing mothers. Its Probiotic Supplements segment offers probiotic supplements in the form of sachets, capsules, and tablets for infants, children, and expectant mothers. The company's adult nutrition and care products segment produces vitamins, health supplements, skincare, and sports nutrition products for adults. Its other pediatric products segment produces dried baby food and nutrition supplements, and baby care products. The company's pet nutrition and care products segment produces food, health supplements, and bone broth products for pets. It is also involved in the research, development, and processing of meat, fruit, and vegetable powder and candy; research, development, manufacture, and sale of special nutritional foods; marketing and distribution of organic baby foods; and wholesale, retail, import, and export of nutritional food and personal care products for infants. In addition, the company engages in the trading and sale of vitamins, health supplements, probiotic skin care, and sports nutrition products for adults. It provides its products under the Biostime, Swisse, Aurelia, Zesty Paws, Solid Gold, Dodie, and Good Gout brands. The company was formerly known as Biostime International Holdings Limited and changed its name to Health and Happiness (H&H) International Holdings Limited in June 2017. The company was founded in 1999 and is headquartered in Quarry Bay, Hong Kong. Health and Happiness (H&H) International Holdings Limited is a subsidiary of Biostime Pharmaceuticals (China) Limited.
One Island East, Quarry Bay, Hong Kong
| Name | Title | Year Born |
|---|---|---|
| Mr. Fei Luo | Chairman | 1964 |
| Mr. Yidong Wang | CFO & Exec. Director | 1974 |
| Ms. Laetitia Marie Edmee Jehanne E. P. Garnier | Exec. Director | 1980 |
| Mr. Akash Bedi | Acting CEO, Chief Strategy & Operations Officer | 1984 |
| Dr. Johannes Jacobus Cappon | Chief Technology Officer | 1966 |
| Ms. Joy Tsai | Director of Investor Relations | NA |
| Mr. Qizhang Zhang | Chief Digital Officer & Chief People Officer | 1984 |
| Mr. Charles Ravel | Managing Director for North America & Asia | 1976 |
| Ms. Pascale Laborde | Global Chief Exec. Officer at Good Goût | 1980 |
| Mr. Howell Wong | Chief Consumer Officer | 1978 |
Disclaimer - This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Please wait processing your request...